#CURLF

[biglisbonnews]

Curaleaf Holdings, Inc. (CURLF) Q1 2023 Earnings Call Transcript https://seekingalpha.com/article/4605545-curaleaf-holdings-inc-curlf-q1-2023-earnings-call-transcript

[stoopidassjamesfranco]

Warrior cats hot take: while Curlfeather is solely an abuser, Splashtail's both an abuser and her victim

[everybody-loves-purdy]

Now that it seems part of Curlfeather's motivation is grief over losing Jayclaw, I'd be really interested to see some kind of parallel between her and Sparkpelt. Both were (judging by Curlf turning against starclan) devastated by losing their mates, and both (unintentionally, in Sparkpelt's case) pressured their child into a path they didn't want. I know a lot of ppl would be worried about Sparkpelt being demonized (I still am tbh, lol) but I think it'd be really interesting to see some kind of examination of why they turned out so differently.

Yeah definitely, it would be really interesting if this is an intentional theme, especially if Jayclaw died of sickness and perhaps if Curlfeather prayed to StarClan frequently spare him but he still died anyway, that could be super interesting

[dayundying]

Imagine if zombie curlf was a dark forest dream and she just looks like that in the df. Warrior cats fans would rejoice. Idk

[marcedrickirby]

CURLF has surged +24.60% to $6.28. Check it out on Yahoo Finance: https://finance.yahoo.com/quote/CURLF.

https://finance.yahoo.com/quote/CURLF.

MARCEDRIC KIRBY FOUNDER CEO.

MARCEDRIC.KIRBY INC.

THE VALLEY OF THE VAMPIRES

[reignforestmagicnugalmanac]

3 Marijuana Stocks With Potential for Massive Growth: April Edition

InvestorPlace recently published an article highlighting three cannabis stocks that have the potential to be multibaggers in the making. These companies are poised for strong growth in the coming months and years. Let’s take a closer look at each of them:

1. Curaleaf Holdings (CURLF): Curaleaf Holdings has seen a significant rally in its stock price over the last 12 months. The company recently completed the acquisition of Northern Green Canada, which will expand its presence in the international market. With a focus on the European medicinal cannabis market, Curaleaf is expecting 2024 to be a catalyst year for growth. The company has a strong presence in the United States and is well positioned for potential federal-level legalization or the reclassification of cannabis as a Schedule III drug.

2. Cronos Group (CRON): Cronos Group is another undervalued cannabis stock with significant growth potential. The company has a cash buffer of $862 million, which is almost equal to its market valuation. Cronos has been making inroads into new markets such as Germany and Australia, and is expected to see accelerated revenue growth as a result. With a positive net change in cash expected for 2024, Cronos has the financial flexibility to support aggressive growth plans through geographic and product portfolio expansion.

3. Tilray Brands (TLRY): Tilray Brands reported strong revenue growth in the last quarter, with international cannabis revenue increasing by 44%. The company has established itself as the fifth-largest craft beer brewer in the United States, providing a strategic infrastructure for expansion once cannabis is legalized at the federal level. With a leading market share in Germany, Tilray is well positioned to capitalize on the recent legalization in the country. The stock has been consolidating in recent months, but is expected to break out on the upside due to positive financial metrics.

In conclusion, these three cannabis stocks have the potential to be multibaggers in the making. With industry tailwinds and positive business developments, these companies are poised for strong growth in the coming years. Investors looking to capitalize on the growing cannabis market may want to consider adding these stocks to their portfolios.

🌿 Dive into the world of cannabis with us! Explore a wide array of products for every stage of your journey, from seeds to grow your plants, to essentials for cultivation and distribution. Whether you're nurturing your first plant or managing a full-scale operation, find all your cannabis needs here. Stay supplied with us! 🌱😗💨

👉 Browse Now!

[otcsocialnetwork]

All Time Trends

All Time Trends: $ERBB $HMBL $RGBP $TGGI $AMBS $NWBO $RNVA $MULN $PHIL $BBBY $FMCC $EEENF $HCMC $ENZC $NSAV $WDLF $RSHN $BIEL $EEGI $FNMA $HPIL $LLKKF $INND $TKGBY $CGMLF $IGEX $AABB $CVSI $FWONB $NVAAF $IMBBY $OTCM $OZSC $EXPGY $BOMO $GVSI $AURI $KYNC $GGII $NEXCF $CURLF $BDGR $HZNFF $TCNNF $PURA $DPLS $CYBL $LCID $KHRNF $SPHRY $COSM $WRMCF $LZRFY $CYDY $LTNC $TXTM $BRCHF $CTEQF $LCLP $STRNY $GFKSY $SING $VYST $AGEEF $VNTH $GNBT $APYP $FDIT $ALYI $GNCP $CBDD $SILXY #PINK $HVCW $SNNSF $ZLDAF $MMTLP $BQSSF $IJJP $MZZMF $ACDVF $MGCLF $SWISF $MLLLF $IPIX $BBIG $NLST $NXTTF $TOMDF $ADRNY $LVCLY $SFOR $CEI $COGZF $RSHYY $DYLLF $BBXTB $MJNA $USMJ $TAUG $OSTBP $ARHLF $KGKG $SANP $OPTI $XXMMF $SHMP $KALY $FRSAF $ANPCY #OTCQB $KNRLF $IVCTF $REPYY $EULIF $TSLA $ACNNF $HLBZ $BLDV $INTWF $QYOUF $BDRBF $RMHB $SBFM $WRHLF $LBRDB $PAOG $INKW $VPER $PQEFF $VRUS $CNTMF $PRVCF $ANSNF $RDFEF $IVPAF $NOUV $FERN $WSRC $TRNLY $TSORF $UBQU $AMC $POTN $SMKG $GTII $RVVTF $IFXY $JSAIY Check out our Free Penny Stock Screener HERE. http://dlvr.it/SmVsDq

[nycannabistimes]

#Repost @marijuanadistribution with @use.repost ・・・ Cannabis stocks fell by some 70% in 2022, compared with the market’s 20% drop. “Buy the dip,” says Cantor Fitzgerald analyst Pablo Zuanic in his January 2023 outlook piece on the weed industry. Cannabis producers in the U.S. and Canada are struggling with weak retail pricing, scarce capital, and persistent U.S. federal restrictions. But over an 18-to-24 month stretch, well-funded U.S. operators could consolidate weak rivals and gain institutional investors with a large-exchange listing. Zuanic’s favorite stocks are the big American chains Curaleaf Holdings CURA +2.75% (ticker: CURLF) and Green Thumb Industries GTII +0.44% (GTBIF), followed by Cresco Labs CL +5.60% (CRLBF) and Trulieve Cannabis TRUL –1.21% (TCNNF). He liked them all the way through last year’s slide, of course. But now he notes that their ground-down stocks leave these growing companies valued at less than two times 2023 sales and eight times earnings before interest, taxes, depreciation and amortization, or Ebitda. | Source: Barrons.com (at New York Stock Exchange) https://www.instagram.com/p/CnCle39rF2G/?igshid=NGJjMDIxMWI=

[don-lichterman]

Curaleaf Celebrates Opening Of Tampa Citrus Park Dispensary

Curaleaf Celebrates Opening Of Tampa Citrus Park Dispensary

According to a Curaleaf / Harris Poll survey, 69% of Americans say they would be more likely to use cannabis as a health solution if it came in small, controlled doses*. Curaleaf recognized this need and created an approachable line for the newer wellness-oriented consumer featuring gummy edibles offering low, customizable doses of THC and high doses of non-psychoactive therapeutic minor…

[robstertan]

I invest in stocks in growing companies in growing industries. Buy if you want. I’m just saying, I bought a lot. You may want to check out this company and tell all your friends!! #Curaleaf #CURLF https://www.instagram.com/p/CEA2v-UndsL/?igshid=1qre0flvm3gqh

[grizzlemedia-blog]

Curaleaf Further Extends Lock-up Period

Curaleaf Holdings Inc. (CNSX: CURA; OTCMKTS: CURLF) announced that the company has struck an agreement with its shareholders to further extend its lock-up period. This new agreement for the lock-up period would only release 5% of the shares owned by insiders on the last day of each calendar quarter starting March 31, 2020. This new agreement comes in connection with Curaleaf's planned closing of the deal to acquire Select, which after the deal closes, will see approximately 62% of the shares outstanding being subject to the new extended lock-up. This is good news for the current shareholders in the short term, as it ensures that the market will not be flooded with a huge supply of Curaleaf shares in the coming few months or so. However, this is more of a stop-gap measure rather than a permanent solution. At some point, insiders would get the chance to sell their shares and this new agreement simply kicks the can down the road. Read the full article

[vadvivon]

what'd curlfeather do?? She seemed nice, just kind of overbearing /nm,

oh man i have a lot of thoughts about her and i love talkiing about it. heres the quick version. she knows and is up to something and its not good. err my interpretation, of course.

she is very much pushing more and more leadership onto frostpaw (and herself) for her or someone elses gain.

“maybe one day frostpaw could (lead)” LIKE?? WHY WOULD YOU EVER SAY THAT. she knows frost doesnt like this leadership stuff and the way she comforts her about it.. shes not comforting frostpaw, she WANTS that to happen. shes putting herself in a place of power above frostpaw.

the dock leaf and feather sign were planted for frostpaw to find and curlfeather had a part in that. she sent frostpaw to her den, and was the first to notice and comment on the dock leaf. THE FEATHER.. curlfeather arranged for frost to go to the moonpool and who would go with her, splashtail. splashtail who was also on the patrol with curlf that reedwhisker disappeared on. ITS SO SUSPICIOUS!!!!!

frost doesnt even wanna be a medicine cat nor is she good at it. she only cares about talking to starclan. this is all because of her mother, curlf has been manipulating her for a LONG time into wanting to be a medicine cat

and her last words??? “trust no cat” like where the hell did that come from? even if the other stuff isnt red flags to anyone (bc its not like ive detailed it well here, sorry) like.. you guys gotta agree that was weird. nothing about how she loves frostpaw.. just planting this seed of distrust in frostpaws head that shes NEVER had in this book.

i think its important frostpaw doubts whether she can trust mothwing. moth is the only cat she mentions by name. moth is the only voice of reason in frosts life and i think curlf knew that. curlf has been pushing mothwing away from frost and the whole clan in this.

sorry im not being very detailed in this, i go way deeper in my goofy twitter thread, but if ppl want i could repost the thread here? i wouldnt mind.

[fortheloveofluxuryxo]

WEED STONKS 🍁💸

YOUTUBE EPISODE

It feels very good to be apart of the wave on innovation in cannabis, crypto, and tech as a whole. I've worked in the cannabis industry for 7 years in a range of jobs - retail/marketing, cultivation, extractions, media - and am now reasearching investing into cannabis stocks. REAL HIGH STONKS potential! There is so much potential for cannabis, it's an incredible herb, and we are only getting started.

I have experienced a small sliver of California go through its legislation phases from the last years of prop 215 (2014), legal medical marijuana, to prop 64 (2016), adult recreational use. Now we have multiple states in the US little by little working on legalization and decriminalization, with New York as the recent state to do so, despite still being federally illegal. Although it can be very enjoyable as a leisure activity, cannabis isn't just a recreational herb, it's a form of healing for a lot of others as cannabis can be consumed in so many ways aside from smoking flower, and the plant has an incredible range of cannabinoids and terpene profiles that can be curated to optimum levels for each person who wants to treat a certain ailment (for example - CBD, CBN, Delta-9 THC, Delta-8 THC, etc). With that said, not only are there medicinal + lifestyle benefits, there is big wealth potential on investing in the cannabis industry within the stock market in the next years to come.

There are a few publically traded American cannabis companies available on the market here in the US and a few others I'm keeping my eye on located in Canada.

Top 10 watch list + ticker 1. Cresco (Illinois) - CRLBF 2. Trulieve (Florida) - TCNNF 3. MedMen (California) - MMNWF 4. Planet 13 (Nevada) - PLNHF 5. Curaleaf Holdings (Massachusetts) - CURLF 6. KushCo Holdings (California) - KSHB 7. Acreage Holdings (Canada & currently running business in New York) - ACRDF 8. Sundial Growers (Canada) - SNDL 9. Aphria (Canada) - APHA 10. Cronos (Canada) - CRON

As news and market movement continues, I anticipate on seeing more activity with these companies. I have also kept my eye on psilocybin stocks and expect to see some movement with that, a slow progression towards drug decriminalization as a whole. I look forward to more focus on decrimininalization with the expunging of records and release of those incriminated by non-violent possesion and sales of marijuana. I also look forward to seeing more black and brown folks create generational wealth with cannabis (and hemp) as the years progress as there are so many sectors in cannabis that can accumulate ample wealth. Cannabis is for the culture, for all. Although legalization news is exciting, it simply isn't enough if it isn't going to be accessible to everyone.

As always, this is not financial advice, just me talking about things I find interesting and as an ideal opportunity for what I'm involved in. Cannabis ignites my solarpunk fantasies into a closer reality! We love to see it! Do your own research. There is a risk in investing, never invest more than you're willing to lose. Happy earning!

More reading What’s New With Cannabis Stocks for the Week Ending 04/02/21 - New Cannabis Ventures Top Marijuana Stocks - Investopedia Cannabis & Psychadelics - Benzinga

[wealthyvc]

+ Technical Chart and Technical Analysis Signal (Buy, Strong Buy, Neutral, Sell, Strong Sell).

Join the TCI Investor Network:

🇺🇸 USA: Text potstocks to 313131 to join

🇨🇦️ CDN: Text potstocks to 393939 to join

Subscribe to email newsletter: https://bit.ly/2Zkseth

[ericvick]

Marijuana Stocks Green Thumb, Trulieve Report Big Profit Gains

U.S. cannabis producer Green Thumb Industries (GTBIF) reported second-quarter earnings after the close Wednesday that beat estimates, helped by sales growth in Illinois and Pennsylvania. Rival Trulieve (TCNNF) reported a big rise in earnings and sales early Thursday.

X

Green Thumb stock, Trulieve and other U.S. marijuana stocks slipped Wednesday,.

The results for the companies will follow those of rival Curaleaf (CURLF) on Monday, and a bigger nationwide push toward cannabis legalization.

Green Thumb Earnings

Green Thumb swung to a profit of 10 cents per share, beating by 2 cents, from a year-ago loss of 6 cents a share. Sales rose 85.4% year-over-year to $221.9 million. That was above forecasts for $207.5 million.

The company said that it brought in sales from all 12 states where it operates. The company’s net income more than doubled to $23.3 million.

Adjusted operating EBITDA — or earnings before interest, taxes, depreciation and amortization — was $79.3 million for the second quarter. That figure excluded $5.7 million in non-cash stock-based compensation and $7.7 million in expenses related to acquisitions and other costs not related to operations.

Green Thumb said it had cash and cash equivalents of $359.2 million as of June 30. Total outstanding debt was $197.6 million.

Green Thumb is based in Chicago, and has benefited from cannabis sales growth in Illinois, its home market, and Pennsylvania. Recreational marijuana is legal in Illinois. Medical marijuana is legal in Pennsylvania. This week, Green Thumb said it was set to open its 62nd dispensary in the nation.

The company last month also acquired Dharma Pharmaceuticals, marking its first move into Virginia. In May, Green Thumb partnered with Cookies, a popular cannabis grower and dispensary chain, to open a Cookies store on the Las Vegas Strip. Green Thumb also recently expanded into Rhode Island.

Green Thumb raised $217 million in senior debt during the quarter, marijuana stocks analyst at Canaccord noted. And it has been expanding grow operations in New York and New Jersey to prepare for the start of recreational sales, Cowen analysts noted. Analysts there have called Green Thumb Industries stock its top pick.

Trulieve Earnings

Estimates: Wall Street expected Trulieve to earn 31 cents per share, a roughly fivefold increase from a year ago. Sales were expected to jump 74% year over year, and 8% from the prior quarter, to $210.2 million.

Results: Adjusted EBITDA grew 55% to $94.9 million, while net income jumped 116% to $40.9 million. Revenue rose 78% to $215.1 million.

Trulieve’s operations have focused on the medical cannabis market in Florida. The company drew virtually all of its sales from there as of March 31.

Trulieve, in recent weeks, said it had begun growing cannabis in West Virginia and opened its first store in Massachusetts. It also has a handful of pot shops and other operations in Pennsylvania, Connecticut and California. It also recently won a Georgia production licenses.

Dow Hits High, Vaccine Makers Dive As White House Sees Covid Hope

Marijuana Stocks

Green Thumb stock, which trades in Canada and over the counter, finished 5% lower during the regular session in the stock market today. The stock’s relative strength line, which compares its performance to the S&P 500, has moved sideways over the past several months.

Among other U.S. marijuana stocks, Curaleaf lost 0.3%. Trulieve was down 2.8%. Shares of those names also trade over the counter and in Canada.

Those multistate operators’ fortunes have grown as more U.S. states legalize medical and adult recreational-use cannabis, even as federal prohibition limits access to banking and loans and keeps the industry from taking normal operating expense deductions.

Still, marijuana stocks analysts say that the large U.S. cannabis companies, disciplined by restrictions, have a clearer path to steady profitability than their Canadian counterparts.

Among Canadian marijuana stocks, Canopy Growth (CGC) fell 2.7% on Wednesday. Tilray (TLRY) was down 2.4%.

YOU MAY ALSO LIKE:

It’s Time To Get Serious About U.S. Marijuana Stocks

Are Any Marijuana Stocks On U.S. Exchanges Good Buys As This One Breaks Out?

Marijuana Stocks To Buy And Watch

Any Reason To Buy Canopy Growth After Earnings?

Looking For Market Insights? Check Out Our IBD Live Daily Segment

[itswallstreetpr]

Future Stars in the Cannabis Stocks Space (GRWG, CURLF, SGMD, TCNNF, ACB, CGC, TLRY)

As the Cannabis space continues to mature, we find ourselves with an “old guard” and a crop of young upstarts racing to steal the torch of leadership away. Given the sharp underperformance of the old guard in recent months, one wonders if the big money in the space has already started to shift its focus. There are valuation and strategy issues to think about as we size this dynamic up for analysis. First off, we know who the old guard is at this point. We’re talking about the likes of Canopy Growth Corp (NYSE:CGC), Aurora Cannabis Inc (NYSE:ACB), and Tilray Inc (NASDAQ:TLRY), among others. Together, these stocks have been dreadful performers in 2019, and valuations are still not exactly enticing. Margin pressure has been the name of the game. That’s why we are starting to look at what we are referring to as: “The Future Stars of the Cannabis Investment Theme”. After all, the notion of overall cannabis industry growth is still completely intact. It’s just a shift in where capital productivity lies. Today, we will look at four interesting prospects: GrowGeneration Corp. (NASDAQ:GRWG), Curaleaf Holdings Inc (OTCMKTS:CURLF), Sugarmade, Inc. (OTCQB:SGMD), and Trulieve Cannabis Corp (OTCMKTS:TCNNF).   GrowGeneration Corp (OTCMKTS:GRWG) is an up-and-comer that is defined by its pick-and-shovel angle on this theme. The company is seeing accelerating growth just as the cultivators are seeing tightening margins. This is a hydroponics player, so it’s able to capitalize the growth in demand and supply. The company just announced that its common shares have been approved for listing on the Nasdaq Capital Market. GrowGeneration Corp. common shares will begin trading on NASDAQ on December 2, 2019 under the trading ticker symbol "GRWG." "This up-listing to NASDAQ is a major corporate milestone and reflects the financial performance of our Company. As the premier hydroponic supplier in the country, we continue to focus on expanding the number of garden centers, increasing our commercial portfolio of customers, focusing on the cutting-edge products, while expanding revenue and EBITDA. We believe our NASDAQ listing will increase long-term shareholder value by improving awareness, liquidity, and appeal to institutional investors" said Darren Lampert, CEO of GrowGeneration Corp. GrowGeneration Corp (OTCMKTS:GRWG) trumpets itself as a company that owns and operates retail hydroponic and organic gardening stores in the United States. It offers horticultural, organics, and lighting and hydroponics products, including lighting fixtures, nutrients, seeds and growing media, systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies, and hand tools. The company serves commercial and urban cultivators growing specialty crops, including organics, greens, and plant-based medicines. As of September 10, 2019, it operated 25 stores, including 5 locations in Colorado, 4 locations in California, 2 locations in Nevada, 1 location in Washington, 4 locations in Michigan, 1 location in Rhode Island, 4 locations in Oklahoma, 1 in New Hampshire, and 3 locations in Maine. GrowGen also operates an online superstore for cultivators, located at HeavyGardens.com. GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. According to company materials, “Our mission is to own and operate GrowGeneration branded stores in all the major states in the U.S. and Canada. Management estimates that roughly 1,000 hydroponic stores are in operation in the U.S. By 2020 the market is estimated to reach over $23 billion with a compound annual growth.” The stock has been acting well over recent days, up something like 12% in that time. Shares of the stock have powered higher over the past month, rallying roughly 7% in that time on strong overall action. GrowGeneration Corp (OTCMKTS:GRWG) managed to rope in revenues totaling $21.8M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 159.1%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($16M against $9.5M).   Curaleaf Holdings Inc (OTCMKTS:CURLF) is increasingly well-known, but continues to have a feel of an “under the radar” name compared to the Old Guard players in the space, despite existing on a scale that actually supersedes some of the more recognizable names – ie, it may surprise you to know that CURLF surpassed TLRY in sales last quarter by over 25%! As a result, CURLF shares are in a very select group being one of just a handful of pot stocks to actually post gains in 2019 – a year that has featured devastating losses for most stocks in the space. Overall, the company roped in revenues of $64.9M during its most recently reported quarterly financial data. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($140.3M against $64.1M). To continue its strong momentum, CURLF recently announced it will launch its custom-designed Veterans Cannabis Project pre-roll product in Florida today. According to the release, a portion of all proceeds will benefit the Veterans Cannabis Project (VCP), an organization that advocates for legal and supported access of medical cannabis for veterans through the Department of Veterans Affairs. In Florida the boxes will be available for $26, and each box contains five 0.4 oz pre-rolls for a total of 2 grams per box. "We are proud to launch the Veterans Cannabis Project initiative in Florida to provide additional support and education for veterans in the communities we serve," said Pablo Arizmendi-Kalb, President of Curaleaf Florida. "Through this partnership with the Veterans Cannabis Project, we hope to increase awareness for veteran access to medical cannabis." Curaleaf Holdings Inc (OTCMKTS:CURLF) operates a large number of dispensaries, 12 cultivation sites and 9 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York. Curaleaf, Inc. leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry's leading resource in education and advancement through research and advocacy.   Sugarmade Inc (OTCMKTS:SGMD) is another example – like GRWG above – of a company positioned to actually benefit from the inevitable margin pinch that has been punishing the “old guard” cannabis cultivators, like Canopy Growth Corp (NYSE:CGC), Aurora Cannabis Inc (NYSE:ACB), and Tilray Inc (NASDAQ:TLRY). As those companies suffer from droves of other growers popping up everywhere to capitalize on expanding legality and demand, a handful of ancillary players, like Sugarmade, are laughing all the way to the bank. As described above, the key point here is that all the producers will need to find strategies to increase efficiency to stay in business as margins tighten. One of the most obvious solutions to that pinch is hydroponics. And Sugarmade is emerging as one of the biggest and fastest-growing hydroponics suppliers in North America, helped by an aggressive M&A roll-up strategy that has already started to pay big dividends. The latest from the company is that it is gearing up to follow GRWG up onto the Nasdaq exchange. “The approval of GrowGen shares for the move up onto the Nasdaq market is a great sign for Sugarmade as we prepare to make a similar move,” commented Jimmy Chan, CEO of Sugarmade. “It’s a positive signal about the hydroponics market and about our overall strategy. It’s time for institutional investors to get heavily involved in the pick-and-shovel ancillary markets surrounding the hemp and hemp-related boom. GrowGen has done a great job, and we are hot on their tail right now, and plan to surpass them in the race to number one in the hydroponics space.” According to this morning’s release, GRWG’s good news is really good news for SGMD as well, given that the two companies are basically twins in terms of revenues, market focus, and scale of operations. SGMD has already booked over $26 million in revenues on a year-to-date basis, and anticipates this number to swell to $32 million on sequential strengthening in gross margins and sales into year end. The company also noted that it is in the process of another major M&A transaction that will significantly further boost overall forward financial projections for 2020. Based on the huge gains seen in GRWG shares as investors see the value of that uplist, the smart money may be quick to line up similar bets in SGMD.   Trulieve Cannabis Corp (OTCMKTS:TCNNF) is in a very select group among cannabis stocks. Like CURLF, Trulieve is actually up this year. And there are just a handful of pot stocks that can claim as much. At this point, you can count the number of cannabis stocks that are positive in 2019 on the fingers of one hand because, as noted above, margins in the space have tightened powerfully, and only a few have managed to adapt and roll with the punches. Helping to foster that successful narrative, the company just announced that it is set to open the doors of its latest Florida location on Tuesday, November 26th, in Lakeland. According to the release, “the Central Florida location is a milestone for Florida's largest operator as Trulieve becomes the first operator in Florida to reach 40 locations. Presently, Trulieve operates 39 other dispensaries throughout the State of Florida, including in the nearby communities of Tampa, Orlando, and Wesley Chapel. The storefront, located on North Florida Avenue in North Lakeland, is part of the company's mission to expand and ensure safe, reliable patient access statewide.” Trulieve Cannabis Corp (OTCMKTS:TCNNF) promulgates itself as a company that engages in the cultivation, possession, distribution, and sale of medical cannabis in the United States. It offers a suite of Trulieve branded products with approximately 125 SKUs, including nasal sprays, capsules, concentrates, syringes, and cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridges. The company distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as takes orders online and by phone for delivery. As of November 20, 2018, the company operated 21 dispensaries. "Trulieve has come a long way over the past three years – from closing out 2016 with only two stores to celebrating our record-breaking 40th store in Florida with even more to come in 2019 — and 2020 – as we continue to strategically plan for the future," said Trulieve CEO Kim Rivers. "As the patient registry continues to grow and Florida's residents continue to seek alternative, natural relief, we will continue our mission to expand access to the natural, effective, and safe medications they have come to rely on." And the stock has been acting well over recent days, up something like 6% in that time. Trulieve Cannabis Corp (OTCMKTS:TCNNF) generated sales of $93.4M, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 20.5% on the top line. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($41.1M against $64.9M, respectively). Read the full article